Zhejiang Longsheng Group stock
600352.SSSHHZhejiang Longsheng Group Co.,Ltd, Basic MaterialsISIN CNE000001FJ4
56Score 56 out of 100, Neutral
Price and trend
47 / 100
Price history
+0.3% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 14% below it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 47).
The price is 34% below its 52-week high. Largest decline in 20 years: 75% (October 2007 to November 2008).
Chart figures for advanced users
- SMA 50$1.77
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$1.92
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)47
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.56
- The lowest closing price of the last twelve months.
- Resistance$2.51
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Zhejiang Longsheng Group Co.,Ltd belongs to the Chemicals (Specialty) industry (China) and, with a market value of $5.38B, is number 59 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $1.99B (down 16.3% year on year) and earnings of $274.19M (down 9.9%).
- MEQIRI Score 56 out of 100 (Neutral): rank 253 of 467 in Basic Materials, median 58.
Show more
- The P/E is 17.2 (Chemicals (Specialty) median 20.2, own median of recent years 13.5).
- Our model puts fair value at $2.74, with the price 38% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 77
- Reliable dividendNo dividend cut for 10 years.Capital allocation 62
- High dividend yieldDividend yield 3.98%, Chemicals (Specialty) median 0.89%.Capital allocation 62
Weaknesses
- Earnings per share fallingDown 15.6% a year since 2020.Growth 20
- Revenue shrinkingRevenue down 3.2% a year since 2020.Growth 20
- Volatile share priceVolatility 46% a year over the last 12 months.
Its standout strengths are valuation and fundamentals, while technical analysis and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Possible value trapClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $1.95 and expensive above $4.56 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $3.54 (cash-flow model) and $1.93 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 7.9%. At 8.9% the fair value would be $2.46, at 6.9% it would be $3.14.
Possible value trap: looks cheap, but weak growth.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (20.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 1.1% on the twelve months before. Revenue has grown solidly since 2006, at about 9% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 29%, operating 14%, net 14%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with moderate debt and comfortable interest coverage.
Earnings
- Next earnings
- 20 Apr 2027in 159 days
- Last reported
- 31 Oct 2026EPS reported $0.03
Analyst estimates
Earnings estimates have barely changed since 23 Oct 2026.
- Earnings per share
- $0.13−0.8%
- Revenue
- $2.59B0.0%
- Earnings per share
- $0.15+0.3%
- Revenue
- $2.98B0.0%
MEQIRI has stored the estimates since 23 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Zhejiang Longsheng Group
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 56
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Inner Mongolia Junzheng Energy & Chemical Group601216.SS $5.87B52
- Gujarat FluorochemicalsFLUOROCHEM.NS $5.66B59
- Hubei Feilihua Quartz Glass300395.SZ $5.58B55
- BalchemBCPC $5.52B73
- Xinjiang Daqo New Energy688303.SS $5.47B32
- LB Group002601.SZ $5.45B46
- Sumitomo Chemical4005.T $5.32B53
- Navin Fluorine InternationalNAVINFLUOR.NS $5.29B79
ETFs that hold Zhejiang Longsheng Group
Held by 30 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| WisdomTree Emerging Markets SmallCap Dividend UCITS ETFWTED | 0.27% | 0.54% | €35.5M |
| Xtrackers Harvest CSI A500 UCITS ETF 1DAH50 | 0.12% | 0.65% | €10.8M |
| HSBC MSCI China A UCITS ETF USDH41K | 0.09% | 0.30% | €68.25M |
Show 5 more
| HSBC MSCI China UCITS ETFH4ZP | 0.02% | 0.28% | €865.21M |
| Franklin FTSE China UCITS ETFFLXC | 0.02% | 0.19% | €1.3B |
| UBS MSCI China Universal UCITS ETF USD disUETC | 0.01% | 0.30% | €134.65M |
| HSBC MSCI Emerging Markets UCITS ETFH410 | 0.01% | 0.15% | €5.12B |
| HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF USDH411 | 0.00% | 0.45% | €400.29M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = CN¥6.6707)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Mar 2021)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
